Abstract
Tumor immunotherapy is supported by low-grade inflammatory conditions in the microenvironment, triggered by immunogenic cell death (ICD). However, ICD is dampened when tumors acquire resistance, affecting immune recognition. KDEL receptors (KDELRs), through a retrograde Golgi-to-ER transport, prevent spontaneous secretion of KDEL proteins. We report that inhibition of a single KDELR in a minor fraction of tumor cells, primarily KDELR2, provokes robust infiltration of macrophages and neutrophils into the tumor microenvironment, resulting in regression of both immunogenic and non-immunogenic tumors initially independently of T cells. Importantly, in the course of regression, anti-tumor T cells are primed, conferring protection against a second challenge. Recapitulated by intratumoral delivery of siDKELR2 utilizing lipid nanoparticles, we implicate KDELR2 as a target to unleash an unusual robust innate immune response, which represents a tractable approach to initiate an adaptive response downstream, bypassing conventional ICD-inducing therapies. We propose KDELR targeting as a strategy to improve immunotherapy across tumor types, including “cold” tumors resistant to T cell-based immunotherapies.
| Original language | English |
|---|---|
| Article number | e76148 |
| Journal | Advanced Science |
| Volume | 13 |
| Issue number | 51 |
| DOIs | |
| State | Published - 14 Sep 2026 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2026 The Author(s). Advanced Science published by Wiley-VCH GmbH.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- ER stress
- calreticulin
- cancer immunity cycle
- immunogenic cell death
- innate immunity
Fingerprint
Dive into the research topics of 'Inhibition of KDEL Receptors Remodels the Tumor Microenvironment for T Cell Independent Tumor Regression'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver